City

Bethesda (1)

Boston (1)

Condition

Multiple Myeloma (2)

Newly Diagnosed Multiple Myeloma (NDMM) (2)

Autologous Stem Cell Transplant (1)

Relapsed and/or Refractory Multiple Myeloma (RRMM) (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 2 (2)

Sponsor

Jacob Laubach (1)

National Cancer Institute (NCI) (1)

Collaborator

Sanofi (1)

Intervention

18f-fdg pet/ct (1)

18f-fluciclovine injection (1)

bortezomib injection (1)

dexamethasone (1)

isatuximab (1)

lenalidomide (1)

Study Documents

Intervention Type

drug (2)

procedure (1)

Funder Type

NIH (1)

Other (1)

Study Type

Interventional (2)

newly diagnosed multiple myeloma (ndmm)

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Multiple Myeloma, Newly Diagnosed Multiple Myeloma (NDMM), Relapsed and/or Refractory Multiple Myeloma (RRMM) Trial run by the

Not yet recruiting

Multiple Myeloma
+2 more

18F-fluciclovine injection
18F-FDG PET/CT

Bethesda, Maryland

National Institutes of Health Clinical Center

Oct 31, 2023

Multiple Myeloma, Newly Diagnosed Multiple Myeloma (NDMM), Autologous Stem Cell Transplant Trial in Boston (Isatuximab,

Recruiting

Multiple Myeloma
+2 more

Isatuximab
+3 more

Boston, Massachusetts

Dana Farber Cancer Institute

Jul 20, 2021